These authors contributed equally to this work. Corresponding to X.D. (biosinodx@gmail.com) and J.V. (jan.vijg@einstein.yu.edu)Activation of retrotransposons and their insertions into new genomic locations, i.e., retrotranspositions (RTs), have been identified in about 50% of tumors. However, the landscape of RTs in different, normal somatic cell types in humans remains largely unknown. Using single-cell whole-genome sequencing we identified 528 RT events, including LINE-1 (L1), and Alu, in 164 single cells and clones of fibroblasts, neurons, B lymphocytes, hepatocytes and liver stem cells, of 29 healthy human subjects aged from 0 to 106 years. The frequency of RTs was found to vary from <1 on average per cell in primary fibroblasts to 7.8 per cell in hepatocytes. Somewhat surprisingly, RT frequency does not increase with age, which is in contrast to other types of spontaneous mutation. RTs were found significantly more likely to insert in or close to target genes of the Polycomb Repressive Complex 2 (PRC2), which represses most of the genes encoding developmental regulators through H3K27me3 histone modification in embryonic stem cells. Indeed, when directly comparing RT frequency between differentiated liver hepatocytes with liver stem cells, the latter were almost devoid of RTs. These results indicate that spontaneous RTs are associated with cellular differentiation and occur, possibly, as a consequence of the transient chromatin transition of differentiation-specific genes from a transcriptionally repressed to activated state during the differentiation process.Retrotransposons are widespread repetitive elements in the genome. They are usually classified into LTR (Long Terminal Repeat) retrotransposons and non-LTR retrotransposons. The latter type is the most abundant and include Long Interspersed Nuclear Element (LINE)-1 (L1), Alu and SVA elements. Together these account for more than one-third of the human genome 1 . Only L1 elements are autonomous retrotransposons and about 100 of them have been demonstrated as still active in the human genome 2-4 . Most are inactivated by truncations, rearrangements and other mutations. L1 elements can be activated, transcribed and, after reverse transcription, reintegrated in the genome 2,5 . While normally repressed, possibly through epigenetic mechanisms 6 , retrotranspositions (RTs) have been reported in both tumors and in the germline 4,7-9 .